Methylation of the promoter CpG regions regulates gene transcription by inhibiting transcription factor binding. Deoxycytidine methylation may regulate cell differentiation, while aberrations in the process may be involved in cancer etiology and the development of birth defects (e.g. neural tube defects). Similarly, nutritional deficiency and certain nutragenomic interactions are associated with DNA hypomethylation. While LC-MS has been used previously to measure percentage genomic deoxycytidine methylation, a lack of a secure source of internal standards and the need for laborious and timeconsuming DNA digestion protocols constitute distinct limitations. Here we report a simple and inexpensive protocol for the biosynthesis of internal standards from readily available precursors. Using these biosynthetic stable-isotopic [U-15 N]-labeled internal standards, coupled with an improved DNA digestion protocol developed in our lab, we have developed a low-cost, high-throughput (`500 samples in 4 days) assay for measuring deoxycytidine methylation in genomic DNA. Inter-and intraassay variation for the assay (%RSD, n = 6) was _2.5%.
INTRODUCTION

CpG islands are 5
0 -deoxycytidine-deoxyguanosine-3 0 -rich regions of DNA. In mammalian cells these regions are initiation sites for DNA transcription (1) . Deoxycytidine methylation (dCyt!MdCyt) of the CpG island plays an important role in regulating gene transcription by blocking transcription factor binding. The inhibition of transcription factor binding increases exponentially with methylation density (2) but can be overcome with increased transcription factor concentrations. Alternatively, the methylated CpG promoter region can act as an initiation site for heterochromatin formation (3), which irreversibly inhibits transcription. By promoting heterochromatin formation, DNA methylation is thought to be a major component of epigenetic gene regulation, i.e. inheritance of information on the basis of gene expression as opposed to gene sequence (genetics). Examples of epigenetic gene regulation include autosomal gene inheritance, where one parental copy is silenced (4) and X-chromosome inactivation in mammals (5) . DNA methylation also is thought to play a role in cell differentiation, as methylation levels are tissue specific (6, 7) and change during tissue maturation (6) .
CpG hypomethylation has been associated with a number of carcinoma types including Wilms tumors (8) (typified by frequent chromosome 1 and chromosome 16 pericentromeric rearrangements), ovarian epithelial carcinoma (8) and breast cancer (9) . DNA hypomethylation also may cause chromosomal instability by promoting stand breakage (10) while the pericentromeric rearrangements observed in the rare genetic disease, immunodeficiency, centromeric heterochromatin instability and facial anomalies (ICF), may be due to the associated hypomethylation of chromosome 1 (11) . DNA methyltransferase inhibitors cause similar a hypomethylation and pericentromeric rearrangement of chromosome 1. Subjects homozygous for the methylenetetrahydrofolate reductase (MTHFR) 677 C!T polymorphism have been shown to exhibit (12) global hypomethylation of DNA, especially when coupled with low plasma folate (512 nmol/l) or red cell folate (51.13 nmol/g hemoglobin) concentrations. It has been suggested that the aberrations in DNA methylation associated with the MTHFR 677 TT genotype may explain why this gene polymorphism is a risk factor for breast (13) , cervical (14) and some colon cancers (15) , and why mothers homozygous for the genotype are at increased risk (16) of having a child with a neural tube defect (NTD).
Despite the potential importance of assessing global DNA methylation no 'gold standard' exists for its measurement. Cytosine extension assays (17) are motif specific, are unable to distinguish between hemi-and fully methylated motifs, and exhibit large inter-($15%) and intra ($4%) assay variability. Methyl-acceptance assays (18) similarly exhibit large inter-($9%) and intra ($5%) assay variability. For both assays intersample variability is probably higher, as both assays are dependent on the quality of the DNA sample (e.g. strand breaks, denatured DNA) which may vary among samples, and the reproducibility with which the DNA concentration can be measured (a single sample of homogenous quality and concentration is typically used to determine inter-and intraassay variability). Furthermore, both of these assays are only semiquantitative, as they provide only a relative measure of dCyt methylation (or rather a measure of unmethylated dCyt in the CpG motif), not an absolute measure. This makes comparisons of samples measured in different labs, or measured on different days, difficult.
In contrast, the LC-MS (or LC-MS/MS) methods provide a quantitative measure of dCyt methylation independently of DNA quality. However, most LC-MS methods lack a readily available and secure source of MdCyt internal standard. For example, while Friso et al. (19) used a labeled MdCyt internal standard when developing their LC-MS method, they needed a custom synthesis. To compensate for a lack of an internal standard, some developers of LC-MS methods have used external standards [intraassay %RSD = 4% (20) ] or pseudo-internal standards, e.g. deoxyguanosine [%RSD = 1.7-9.2% (21, 22) ]. In the absence of an internal standard, no correction can be made for sample recovery during preparation and for changes in ionization efficiency between runs (e.g. due to ion suppression, detector contamination, changes in gas pressures, detector saturation or changes in running buffer).
Consequently, we devised a simple and inexpensive protocol for synthesizing [U- 15 15 N]-labeled growth medium. This second culture was grown to lag-phase ($24-h growth), at which point the bacteria were harvested by centrifuging at 300 g for 10 min. Bacterial DNA was extracted using a Bactozol Kit (Molecular Research Center, Cincinnati, OH) according to the manufacturer's instructions. The Bactazol Kit includes an RNA hydrolysis step allowing for the selective precipitation of DNA from cell lysates. The DNA pellet was washed twice with 75% v/v ethanol and reconstituted ($50 mg/ml) in 10 mM Tris-HCl, 50 mM NaCl, 1 mM dithiothreitol, 10 mM MgCl 2 (pH 7.9).
[U- 15 
DNA digestion
DNA was quantified using a PicoGreen kit (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Digest Mix (enough for 100 samples) was prepared using 250 U Benzonase, 300 mU phosphdiesterase, 200 U alkaline phosphatase, 200 ml of digested [U-
15 N]DNA (equivalent to $10 mg DNA) and 0.5 ml 10Â Buffer [100 mM Tris-HCl, 500 mM NaCl, 100 mM MgCl 2 (pH 7.9)], and made up to 5 ml with water. DNA samples (1 mg in 50-ml water) were digested by adding 50 ml Digest Mix and incubating at 378C for 6 h.
Liquid hromatography-tandem mass spectroscopy
Sample injection was 10 ml (equivalent to 100 ng DNA). DNA digests were chromatographed using a 3 mm Luna C 18 (2) column (50 Â 3 mm, Phenomenex, Torrance, CA) eluted with 5 mmol/l ammonium acetate/0.1% (v/v) acetic acid using a methanol gradient at a flow rate of 0.5 ml/min. The methanol gradient increased linearly from 4% to 18% over 3.5 min. where it was held for 1.5 min, after which it returned to baseline (4%). There was a 1-min delay before the next injection-not allowing the column to fully equilibrate improved the peak shape. Total run time (injection to injection) was 6 min.
Samples were analyzed in ESI mode using a triple quadrupole mass spectrometer. For the determination of isotopic nucleosides enrichment scanning was performed in positive ionization mode using selected reaction monitoring ( cm -1 at 286 nm (25) . A stock mixture of the two standards was carefully prepared to give an exact known concentration ratio of dCyt to MdCyt (typically on the order of 12:1). The stock solution was further diluted to make a working solution. A standard curve was prepared from the working solution by serially dilution with water ( Figure 1 ). To 50 ml of each standard dilution was added 50 ml of the Digest Mix (containing the [U-
15 N] internal standards). Standard curves were prepared by plotting the analyte/internal standard ratio (M+0/M+3) against nucleoside concentration.
Determining percentage deoxycytidine methylation
The concentration of dCyt and MdCyt in each sample was calculated from the standard curves using the analyte/ internal standard ratio (M+0/M+3) by reverse prediction. Percentage dCyt methylation (%MdCyt) was calculated by dividing the MdCyt concentration by the total dCyt concentration ([dCyt] + [MdCyt]).
Inter-and intraassay variability
Intraassay variability was determined by running six replicate DNA samples within the same run. Interassay variability was determined by running six replicate DNA samples on 6 consecutive days.
Effect of [U-
15 N]DNA concentration on measured deoxycytidine methylation
To determine the effect of variations in the volume (e.g. due to pipetting error) of added [U-
15 N]DNA internal standard had on %MdCyt, 50 ml of a stock dCyt and MdCyt mixture were spiked (in triplicate) with 25, 50 or 75 ml of the Digest Mix. Concentrations of dCyt and MdCyt were determined as described above, as was %MdCyt.
Preparation of stock DNA mixtures of varying percentage DNA methylation Using a REPLI-g Midi kit (Qiagen, Valencia, CA) 100 ng of pooled lymphocyte DNA was amplified to $40 mg according to the manufacturer's instructions. Amplification produces an unmethylated end product that, according to the manufacturer's literature, is essentially fully double stranded. The amplified DNA was divided, and half was methylated using SssI (CpG) methyltransferase (New England Biochemicals). The DNA was purified using a Qiaex II Gel Extraction Kit (Qiagen). The methylated and unmethylated DNA was mixed to give a series of samples with known ratios of methylated to unmethylated DNA. Percentage DNA methylation for each sample was determined by LC-MS/ MS as described above.
Methyl-acceptance assay
DNA samples showing wide variability in methylation (as determined by LC-MS/MS) were identified from a folate intervention study (26) . The relative abundance of unmethylated cytosines in the CpG motif in these samples was determined using a modification (27) (28) . In brief, DNA (0.5 mg) was incubated with SssI methyltransferase (New England Biolabs, Beverly, MA) and [ 3 H]methyl S-adenosylmethionione (New England Nuclear, Boston) at 308C for 4 h. The DNA was collected on a DE81 ionexchange filter. After washing, to remove unincorporated label, the dried filter paper was counted in a liquid scintillation counter. Each DNA sample was analyzed in triplicate. Typical inter-and intraassay variability determined using a pooled lymphocyte DNA sample were 10 and 7%, respectively.
RESULTS AND DISCUSSION
Liquid chromatography-tandem mass spectroscopy
The chromatographic conditions gave good separation of dCyt and MdCyt (Figure 2) . The relatively high specificity of the mass transitions employed yielded good signalto-noise ratios with negligible appearance of contaminating peaks. 
Standard curves
After adjusting for internal standard recovery (M+0/ M+3), standard curves were linear over the range of interest (dCyt: 1-100 mmol/l; MdCyt: 0.1-10 mmol/l; P ! 0.999) and over a range at least an order of magnitude higher and lower.
Inter-and intraassay reproducibility and variability
The assay exhibited good reproducibility and little inter-(4.36%; %RSD = 2.36%; n = 6) and intraassay (4.33%; %RSD = 2.49%; n = 6) variability. The importance of using an internal standard was evident from the large variability observed for the unadjusted dCyt and MdCyt peak areas (Table 1 ). This was particularly evident for MdCyt determination, where a large decrease in peak area ($25%) was observed between the third and subsequent samples, resulting in a large variation in peak area (%RSD % 20%). However, as the response of the [ 15 N 3 ]MdCyt internal standard was similarly affected (as would be expected), the %RSD for the corrected MdCyt peak area (M+0/M+3) was only 2.54%. Six replicates of a pooled sample were independently digested and analyzed consecutively by LC-MS/MS, as described in the text. 
Effect of varying internal standard or sample DNA concentrations
As expected, the volume of internal standard added to the sample greatly affected (Table 2 ) apparent dCyt and MdCyt concentration. In contrast, %MdCyt values were independent of the internal standard concentration. Similarly, when changing the sample DNA concentration (using 0.5, 1.0 or 1.5 mg) the measured concentrations of dCyt and MdCyt increased with DNA concentration, while the %MdCyt was consistent (%RSD = 2.3%; data not shown). Consequently, the amount of internal standard or sample DNA used in the assay has little effect on the measured %MdCyt.
Linearity of DNA admix
The REPLI-g amplified product exhibited little (50.1%) DNA methylation while the post methylated (with SssI) DNA had 3.94% DNA methylation. Admixes of the methylated and unmethylated DNA, containing different fixed ratios of the methylated and unmethylated DNA, exhibited ( Figure 3 ) good linearity (r = 0.9998) when assayed by LC-MS/MS.
Comparison of LC-MS/MS and [ 3 H]methyl-acceptance assay results
Results from the LC-MS/MS assay and the [ 3 H]methylacceptance assay are not directly comparable as the LC-MS/MS assay quantitatively measures the percentage of methylated dCyt in the sample, while the [ 3 H]methyl-acceptance assay semiquantitatively measures the number of unmethylated dCyt in the CpG motif (e.g. the results from both assays are, at best, inversely proportional). However, within the confines of the assay (particularly the [ 3 H]methyl-acceptance assay) the two assays showed good agreement with each other (Table 3) , with samples with a relatively low %MdCyt exhibiting a relatively high methyl-acceptance capacity.
Sample throughput and clinical applications
Using a Repeater Pipetter (Eppendorf) it was possible to add Digest Mix to each well of a 96-well plate in 52 min. In this manner 4500 pre-plated samples (26,29) could be digested in a single day. These 4500 samples could then be analyzed LC-MS/MS in 53 days, due to the short chromatography time for each sample (6 min. from injection to injection). 
CONCLUSION
